Literature DB >> 22630091

Efficacy of single dose perioperative intravenous steroid (dexamethasone) for postoperative pain relief in tonsillectomy patients.

Khalid Buland1, Muhammad Umar Zahoor, Adnan Asghar, Shahram Khan, Ameer Yasser Zaid.   

Abstract

OBJECTIVE: To determine the efficacy of single dose perioperative intravenous steroid (dexamethasone) for postoperative pain relief in patients undergoing tonsillectomy. STUDY
DESIGN: Quasi-experimental study. PLACE AND DURATION OF STUDY: Combined Military Hospital, Lahore, from November 2009 to June 2010.
METHODOLOGY: Sixty patients were divided into two equal groups. A single dose of dexamethasone was given to patients of group A during induction of anaesthesia, whereas no steroid was given to the patients in group B. Postoperative pain scores were assessed at 2, 6 and 12 hours in both groups using visual analogue scale (VAS). Pain was classified as mild (0-3), moderate (4-7) and severe (8-10) on visual analogue scale.
RESULTS: There was no significant difference in pain scores after 2 hours postoperatively. Pain scores of Group A at 6 and 12 hours postoperatively were found to be significantly low than Group B.
CONCLUSION: Single dose perioperative intravenous injection of dexamethasone in tonsillectomy patients reduces postoperative tonsillectomy pain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22630091     DOI: 06.2012/JCPSP.349352

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  2 in total

1.  Comparing the impact of intraperitoneal hydrocortisone with bupivacaine on postoperative pain after laparoscopic cholecystectomy.

Authors:  Shahram Amini; Amene Sabzi Sarvestani
Journal:  Anesth Pain Med       Date:  2014-09-08

2.  Intraperitoneal hydrocortisone for pain relief after laparoscopic cholecystectomy.

Authors:  Amene S Sarvestani; Shahram Amini; Mohsen Kalhor; Reza Roshanravan; Mehdi Mohammadi; Amir Hussein Lebaschi
Journal:  Saudi J Anaesth       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.